Clinical Trials Directory

Trials / Unknown

UnknownNCT06179797

Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Augusta University · Academic / Other
Sex
All
Age
56 Years
Healthy volunteers
Not accepted

Summary

To evaluate the dose-response of relevant blood biomarkers to remote ischemic conditioning in patients with age-related cerebral white matter hyperintensities on MRI, in preparation for a subsequent larger efficacy trial.

Detailed description

Objective: The objective of this early phase study is to evaluate the dose-response of relevant blood biomarkers to remote ischemic conditioning in preparation for a subsequent larger efficacy trial. In addition, we will evaluate the tolerability and adherence to the treatment protocol. Aim: We aim to measure blood biomarkers in response to daily remote ischemic conditioning (RIC) using a dose escalation study design in 40 patients with age-related cerebral white matter hyperintensities on MRI. Hypothesis: We hypothesize that there will be a significant change in the biomarker levels in a dose dependent fashion.

Conditions

Interventions

TypeNameDescription
DEVICEremote ischemic conditioningsuprasystolic BP sequential compression of both arms with blood pressure cuffs for 5 min on/off for 4 cycles.

Timeline

Start date
2020-08-15
Primary completion
2023-12-15
Completion
2023-12-15
First posted
2023-12-22
Last updated
2023-12-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06179797. Inclusion in this directory is not an endorsement.